1. Home
  2. IMMX vs AVNW Comparison

IMMX vs AVNW Comparison

Compare IMMX & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$6.34

Market Cap

306.2M

Sector

Health Care

ML Signal

HOLD

Logo Aviat Networks Inc.

AVNW

Aviat Networks Inc.

HOLD

Current Price

$22.37

Market Cap

275.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMX
AVNW
Founded
2014
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
306.2M
275.0M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
IMMX
AVNW
Price
$6.34
$22.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$12.00
$32.50
AVG Volume (30 Days)
1.0M
103.5K
Earning Date
11-07-2025
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.11
Revenue
N/A
$446,772,000.00
Revenue This Year
N/A
$5.73
Revenue Next Year
N/A
$6.79
P/E Ratio
N/A
$20.13
Revenue Growth
N/A
2.92
52 Week Low
$1.34
$15.80
52 Week High
$7.73
$26.83

Technical Indicators

Market Signals
Indicator
IMMX
AVNW
Relative Strength Index (RSI) 65.80 57.08
Support Level $5.73 $21.46
Resistance Level $6.33 $21.98
Average True Range (ATR) 0.48 0.93
MACD 0.14 0.09
Stochastic Oscillator 93.78 56.47

Price Performance

Historical Comparison
IMMX
AVNW

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About AVNW Aviat Networks Inc.

Aviat Networks Inc provides wireless transport and access networking solutions designed to support telecommunications operators and private network providers situated in various countries. The company offers a range of microwave and millimeter wave radios, network management tools, and services that enable high-capacity, secure, and reliable data transport over wireless networks. Its products serve diverse clients including mobile operators, public safety organizations, utilities, government agencies, and enterprise customers. Aviat generates revenue from the sale of its networking equipment, professional services, and ongoing support contracts. Its operations cover various regions including the Americas, Europe, Asia Pacific, the Middle East, and Africa.

Share on Social Networks: